- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
3D Systems Previews D2P Software Solution for Converting Medical DICOM Data to Digital 3D Models
3D Systems expands end-to-end healthcare workflow facilitating creation of 3D models for pre-operative surgical planning D2P software to deliver patient specific digital models that can be exported for use in various applications including CAD software, virtual reality visualizations and 3D printing 3D Systems (NYSE:DDD) previewed today its D2P™ (DICOM-to-Print) software solution for rapidly converting patient …
- 3D Systems expands end-to-end healthcare workflow facilitating creation of 3D models for pre-operative surgical planning
- D2P software to deliver patient specific digital models that can be exported for use in various applications including CAD software, virtual reality visualizations and 3D printing
3D Systems (NYSE:DDD) previewed today its D2P™ (DICOM-to-Print) software solution for rapidly converting patient specific medical data into digital 3D models. A planned enhancement to the company’s end-to-end healthcare workflow, D2P is designed to make it easier than ever for doctors to practice and plan complex surgical procedures using digital 3D anatomical models as well as facilitate the printing of physical 3D anatomical models. Visitors to the Radiological Society of North America Annual Meeting (RSNA) will be able to preview D2P in 3D Systems’ booth 1558.
“Our goal with D2P is to provide medical professionals with greater knowledge and productivity by enabling easier access to 3D models,” said Kevin McAlea, EVP, General Manager, Metals & Healthcare, 3D Systems. “This represents a significant step forward for our end-to-end healthcare solution.”
From anatomical models and 3D printers to virtual reality visualizations, 3D Systems’ comprehensive portfolio of healthcare solutions will be on display in booth 1558 at RSNA 2016 in Chicago, IL, November 27 – December 2.
For more information on 3D Systems’ healthcare applications and offerings, contact healthcare@3dsystems.com
D2P™ is patent pending and pending 510(K). It is not commercially available at this time.
About 3D Systems
3D Systems provides comprehensive 3D products and services, including 3D printers, print materials, on demand manufacturing services and digital design tools. Its ecosystem supports advanced applications from the product design shop to the factory floor to the operating room. 3D Systems’ precision healthcare capabilities include simulation, Virtual Surgical Planning, and printing of medical and dental devices as well as patient-specific surgical instruments. As the originator of 3D printing and a shaper of future 3D solutions, 3D Systems has spent its 30 year history enabling professionals and companies to optimize their designs, transform their workflows, bring innovative products to market and drive new business models.
More information on the company is available at www.3dsystems.com
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.